BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Diagnosis
14 results:

  • 1. Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood cancer.
    Lazo De La Vega L; Comeau H; Sallan S; Al-Ibraheemi A; Gupta H; Li YY; Tsai HK; Kang W; Ward A; Church AJ; Kim A; Pinto NR; Macy ME; Maese LD; Sabnis AJ; Cherniack AD; Lindeman NI; Anderson ME; Cooney TM; Yeo KK; Reaman GH; DuBois SG; Collins NB; Johnson BE; Janeway KA; Forrest SJ
    JCO Precis Oncol; 2022 Nov; 6():e2200390. PubMed ID: 36446043
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics.
    Vagvala S; Guenette JP; Jaimes C; Huang RY
    Cancer Imaging; 2022 Apr; 22(1):19. PubMed ID: 35436952
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neuroradiological features of the polymorphous low-grade neuroepithelial tumor of the young: five new cases with a systematic review of the literature.
    Kurokawa M; Kurokawa R; Capizzano AA; Baba A; Ota Y; Pinarbasi E; Johnson T; Srinivasan A; Moritani T
    Neuroradiology; 2022 Jun; 64(6):1255-1264. PubMed ID: 35001164
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
    Ahrendsen JT; Sinai C; Meredith DM; Malinowski SW; Cooney TM; Bandopadhayay P; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1052–1059. PubMed ID: 34580728
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic and epigenetic landscape of IDH-wildtype glioblastomas with fgfr3-TACC3 fusions.
    Mata DA; Benhamida JK; Lin AL; Vanderbilt CM; Yang SR; Villafania LB; Ferguson DC; Jonsson P; Miller AM; Tabar V; Brennan CW; Moss NS; Sill M; Benayed R; Mellinghoff IK; Rosenblum MK; Arcila ME; Ladanyi M; Bale TA
    Acta Neuropathol Commun; 2020 Nov; 8(1):186. PubMed ID: 33168106
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeted Therapy with Anlotinib for a Patient with an Oncogenic fgfr3-TACC3 Fusion and Recurrent Glioblastoma.
    Wang Y; Liang D; Chen J; Chen H; Fan R; Gao Y; Gao Y; Tao R; Zhang H
    Oncologist; 2021 Mar; 26(3):173-177. PubMed ID: 32949176
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational study.
    Nørøxe DS; Yde CW; Østrup O; Michaelsen SR; Schmidt AY; Kinalis S; Torp MH; Skjøth-Rasmussen J; Brennum J; Hamerlik P; Poulsen HS; Nielsen FC; Lassen U
    Mol Oncol; 2020 Nov; 14(11):2727-2743. PubMed ID: 32885540
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recurrent Papillary Glioneuronal Tumor.
    Goethe EA; Youssef M; Patel AJ; Jalali A; Goodman JC; Mandel JJ
    World Neurosurg; 2019 Aug; 128():127-130. PubMed ID: 31078809
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Low-grade neuroepithelial tumor: Unusual presentation in an adult without history of seizures.
    Riva G; Cima L; Villanova M; Ghimenton C; Sina S; Riccioni L; Munari G; Fassan M; Giangaspero F; Eccher A
    Neuropathology; 2018 Oct; 38(5):557-560. PubMed ID: 30051533
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metachronous Medulloblastoma in a Child With Successfully Treated Neuroblastoma: Case Report and Novel Findings of DNA Sequencing.
    Eterovic AK; Maher OM; Chandra J; Chen K; Huse J; Zaky W
    J Natl Compr Canc Netw; 2018 Jun; 16(6):683-691. PubMed ID: 29891519
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Clinical analysis of paraneoplastic neurological syndrome associated with thymoma].
    Liu HS; Ren HT; Zhou LX; Li SQ; Peng B; Cui LY; Guan HZ
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(35):2770-2774. PubMed ID: 28954337
    [No Abstract]    [Full Text] [Related]  

  • 13. Improved Pharmacokinetics Following PEGylation and Dimerization of a c(RGD-ach-K) Conjugate Used for Tumor Positron Emission Tomography Imaging.
    Lee JW; Lee YJ; Shin UC; Kim SW; Kim BI; Lee KC; Kim JY; Park JA
    Cancer Biother Radiopharm; 2016 Oct; 31(8):295-301. PubMed ID: 27754748
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.
    Assietti R; Olson JJ
    J Neurooncol; 1996 Mar; 27(3):251-8. PubMed ID: 8847559
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.